Anfield Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-391
| Closed | -$15.9K | – | 74 |
|
|
2022
Q4 | $15.9K | Hold |
391
| – | – | 0.01% | 83 |
|
|
2022
Q3 | $26K | Buy |
391
+18
| +5% | +$1.2K | 0.01% | 83 |
|
|
2022
Q2 | $23K | Buy |
373
+72
| +24% | +$4.44K | 0.01% | 86 |
|
|
2022
Q1 | $19K | Buy |
301
+165
| +121% | +$10.4K | 0.01% | 89 |
|
|
2021
Q4 | $10K | Buy |
136
+125
| +1,136% | +$9.19K | ﹤0.01% | 92 |
|
|
2021
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 109 |
|